2019 Archives - Keystoneheart

Sign Up for Keystone Heart Updates

(813) 530-8200

info@keystoneheart.com

Search

Who We Are
Patients
- Patient Information
- FREQUENTLY ASKED QUESTIONS (FAQs)
Healthcare Professionals
- Interviews
- Videos
Products
- TriGUARD 3™ CEP Device Technology
Clinical Evidence
News

Who We Are
Patients
- Patient Information
- FREQUENTLY ASKED QUESTIONS (FAQs)
Healthcare Professionals
- Interviews
- Videos
Products
- TriGUARD 3™ CEP Device Technology
Clinical Evidence
News

Search:

Blog Category

Blog Category

Press Release Category

Press Release Category

News Category

News Category

No posts were found.

Search for:

Press Releases

2020
2019
2018
2017
2016
2015
2012

Category

2020
2019
2018

Categories

2020
2019
2018

Additional Information

About Us
TriGUARD 3™ CEP Device Technology
Abstracts
News
Press Releases
Contact Us

The Only CE Marked Cerebral Embolic Protection Device Designed to Cover all Three Major Aortic Vessels.

A Venus Medtech Company

Important Links

About Us
Clinical Studies
Patient Information
Presentations
Products
News
Careers
Contact Us

Disclaimer

The TriGUARD 3™ Cerebral Embolic Protection Device is CE marked. Approved for investigational use only in the US, not cleared by the US FDA.

“TriGUARD cerebral Embolic Protection Device” and TriGUARD 3™ cerebral Embolic Protection Device are trademarks owned by Keystone Heart, LTD. and may be registered. All other trademarks are the property of their respective owners.

Copyright Keystone Heart, A Venus Medtech Company 2021

Privacy Policy
Disclaimer

Site By Tarika Technologies™

Skip to content

Accessibility Tools

Increase Text
Decrease Text
Grayscale
High Contrast
Negative Contrast
Light Background
Links Underline
Readable Font
Reset